Meta-analysis: effectiveness of drugs for preventing contrast-induced nephropathy.
about
Fenoldopam for preventing and treating acute kidney injuryFenoldopam for preventing and treating acute kidney injuryAcute kidney injury in the perioperative period and in intensive care units (excluding renal replacement therapies)Prevention of contrast-induced AKI: a review of published trials and the design of the prevention of serious adverse events following angiography (PRESERVE) trial.Measures used to treat contrast-induced nephropathy: overview of reviewsRadiographic contrast-media-induced acute kidney injury: pathophysiology and prophylactic strategies[Acute renal failure and sepsis : Just an organ dysfunction due to septic multiorgan failure?].Contrast-induced acute kidney injury: specialty-specific protocols for interventional radiology, diagnostic computed tomography radiology, and interventional cardiology.Sodium bicarbonate for the prevention of contrast-induced nephropathy: a meta-analysis of 17 randomized trials.Preventing contrast-induced nephropathy: problems, challenges and future directions.Pentoxifylline and prevention of contrast-induced nephropathy: Is it efficient in patients with myocardial infarction undergoing coronary angioplasty?Contrast induced nephropathy in urology.Efficacy of alprostadil for preventing of contrast-induced nephropathy: A meta-analysis.Contrast-induced acute kidney injury and renal support for acute kidney injury: a KDIGO summary (Part 2).Prevention of acute kidney injury and protection of renal function in the intensive care unit: update 2017 : Expert opinion of the Working Group on Prevention, AKI section, European Society of Intensive Care Medicine.Statins for the prevention of contrast-induced nephropathy: a systematic review and meta-analysis.Prevention of contrast-induced nephropathy: A randomized controlled trial of sodium bicarbonate and N-acetylcysteineSubdural fluid collections in patients with infantile neuronal ceroid lipofuscinosis.Successful Percutaneous Renal Artery Angioplasty and Stenting for Acute Oliguric Renal Failure in a Solitary Functioning Kidney Caused by Takayasu's ArteritisMechanisms for an effect of acetylcysteine on renal function after exposure to radio-graphic contrast material: study protocol.Clinical pearls in nephrologyEfficacy of short-term high-dose statin pretreatment in prevention of contrast-induced acute kidney injury: updated study-level meta-analysis of 13 randomized controlled trialsAlbuminuria and estimated glomerular filtration rate independently associate with acute kidney injury.Cardiological Society of India practice guidelines for angiography in patients with renal dysfunction.N-acetylcysteine does not prevent contrast nephropathy in patients with renal impairment undergoing emergency CT: a randomized study.The effect of the time interval between coronary angiography and on-pump cardiac surgery on risk of postoperative acute kidney injury: a meta-analysis.Furosemide with saline hydration for prevention of contrast-induced nephropathy in patients undergoing coronary angiography: a meta-analysis of randomized controlled trialsDetermination of safe contrast media dosage to estimated glomerular filtration rate ratios to avoid contrast-induced nephropathy after elective percutaneous coronary intervention.Atorvastatin and prevention of contrast induced nephropathy following coronary angiography.Incidence and outcome of contrast-associated acute kidney injury assessed with Risk, Injury, Failure, Loss, and End-stage kidney disease (RIFLE) criteria in critically ill patients of medical and surgical intensive care units: a retrospective study.Effect of N-acetylcysteine pretreatment of deceased organ donors on renal allograft function: a randomized controlled trialLaboratory prediction of the requirement for renal replacement in acute falciparum malaria.Outcome of critically ill patients with acute kidney injury using the Acute Kidney Injury Network criteriaThe prevention of acute kidney injury an in-depth narrative review: Part 2: Drugs in the prevention of acute kidney injury.Preconditioning With Tauroursodeoxycholic Acid Protects Against Contrast-Induced HK-2 Cell Apoptosis by Inhibiting Endoplasmic Reticulum Stress.Methylxanthines and the kidney.Efficacy of preventive interventions for iodinated contrast-induced acute kidney injury evaluated by intrarenal oxygenation as an early marker.Evaluation of N-acetylcysteine for the prevention of contrast-induced nephropathy.Percutaneous panvascular intervention in an unusual case of extensive atherosclerotic disease.Reference renal artery diameter is a stronger predictor of contrast-induced nephropathy than chronic kidney disease in patients with high cardiovascular risk.
P2860
Q24188272-243550DA-12FB-4F1A-9B7C-2B629A51601CQ24198276-03B7B076-83A2-442C-9B8B-E305714EE827Q26745670-D13CEF26-C8F9-4037-A0F0-D478FFABDBB1Q26823226-E05A3CFC-F597-446D-BD1E-E16B7A69E229Q26849704-1060953B-BEA9-4D1B-862D-608A6C9533ACQ27021421-524B4087-EEEC-4AAC-9A5C-4B2FBE36944AQ30318604-CAB42503-372C-464C-BD36-B3DD1A09E78FQ30439077-88239438-ADA1-4B36-A1E1-460E62D7A45AQ33435406-84B3FF46-E836-4D64-840C-65C3225131DFQ33445312-1ABEEE56-48F8-4755-849C-78354584FCC7Q33596949-B73205CF-B5BF-437A-9FFE-865464A7045AQ33599720-C91DC5DA-9775-4F2B-B67C-4AC2E824BCD6Q33682670-14A98C48-AF4A-4053-B8A9-2CC555E0DCE2Q33752736-463FBF0F-993E-4C56-833A-605F248AC24EQ33843623-795BD6E0-1268-48E3-A13A-A0118E9424A3Q33853657-7514B10F-7E16-4E09-9D78-82298F79CDD0Q33989419-9072DB4D-5023-412C-989E-EC50FC19B7B5Q34067499-47D0B477-76C1-47B0-A22B-791BB876D9B7Q34104588-6E538E0C-AA20-4FDF-8F7D-E5AB62103CB0Q34150613-4B0158FC-D3F8-4097-9BCF-CA5FFDC37E4EQ34252437-4CB341E2-EA91-406A-B42B-EBA6C919FA85Q34450309-D7BA6B40-412A-43B9-82E7-E575F18EBFBEQ34455487-FC2EBDE4-BFDF-4630-9B4F-8F986403B0B4Q34574872-4FD9B3C2-E34C-4FA0-8094-77BD719795AEQ34753666-049B6FB3-898E-4E89-B2EB-12AD108AF8B3Q34895329-6AA08EAE-0750-4A92-8BDD-22BEC5311804Q35044091-53D7C7D4-CBCC-4255-900C-920998D1CB41Q35048384-96E8DCDE-FB5A-40A4-99A7-EF3D626E1FACQ35160480-50A8B11D-98F2-44DE-AC80-8B8789D4F594Q35180244-60819DE4-EAC7-4BF8-BDFD-40986EFA12F9Q35223440-096D73E6-1DD3-47AA-A4AD-EA54B73C497BQ35428615-14A164A6-219F-47C2-A0CE-5A3285BB093CQ35541694-189A9AE7-DE17-4132-8244-2C8F9E1A8762Q35574190-B6E52CC7-F2D7-400A-8A7E-95E8FA85B04CQ35589207-85ADF271-8668-47AC-BCD8-B0CFEEBC1C5DQ35745752-23F100A4-5796-4EF0-A28C-F24984EB56F8Q35751549-996A7017-E6F7-4122-AAE1-CA17B832BDF2Q35762221-C64F658C-E533-4AF9-A865-A9C5965C629BQ35788973-71584D12-D9F9-431C-B3C8-AC7C1D58CFCFQ35791812-C2001A0E-220F-48A0-AB52-BFB0E2B64B4E
P2860
Meta-analysis: effectiveness of drugs for preventing contrast-induced nephropathy.
description
2008 nî lūn-bûn
@nan
2008 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Meta-analysis: effectiveness of drugs for preventing contrast-induced nephropathy.
@ast
Meta-analysis: effectiveness of drugs for preventing contrast-induced nephropathy.
@en
Meta-analysis: effectiveness of drugs for preventing contrast-induced nephropathy.
@nl
type
label
Meta-analysis: effectiveness of drugs for preventing contrast-induced nephropathy.
@ast
Meta-analysis: effectiveness of drugs for preventing contrast-induced nephropathy.
@en
Meta-analysis: effectiveness of drugs for preventing contrast-induced nephropathy.
@nl
prefLabel
Meta-analysis: effectiveness of drugs for preventing contrast-induced nephropathy.
@ast
Meta-analysis: effectiveness of drugs for preventing contrast-induced nephropathy.
@en
Meta-analysis: effectiveness of drugs for preventing contrast-induced nephropathy.
@nl
P2093
P1476
Meta-analysis: effectiveness of drugs for preventing contrast-induced nephropathy.
@en
P2093
Aine M Kelly
Ben Dwamena
Paul Cronin
Ruth C Carlos
Steven J Bernstein
P304
P356
10.7326/0003-4819-148-4-200802190-00007
P407
P577
2008-02-01T00:00:00Z